U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H29N5O3
Molecular Weight 387.476
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUQUINERAN

SMILES

CCCCNC(=O)NC1CCN(CC1)C2=C3C=C(OC)C(OC)=CC3=NC=N2

InChI

InChIKey=CPZHDDGPHQRMEJ-UHFFFAOYSA-N
InChI=1S/C20H29N5O3/c1-4-5-8-21-20(26)24-14-6-9-25(10-7-14)19-15-11-17(27-2)18(28-3)12-16(15)22-13-23-19/h11-14H,4-10H2,1-3H3,(H2,21,24,26)

HIDE SMILES / InChI
Buquineran (UK14275), an inotropic compound, is a coronary vasolidator agent. It has been shown to exert a powerful inotropic effect with minimal effect on heart rate in dogs. Buquineran is a phosphodiesterase inhibitor. It acted as potent inhibitor of cyclic AMP hydrolysis catalysed by both PDE-II and PDE-III enzymes.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
7.6 µM [IC50]
PubMed

PubMed

TitleDatePubMed
Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
1987-12-01
Lack of inotropic selectivity of phosphodiesterase enzyme inhibitors in-vitro.
1987-09
Patents

Sample Use Guides

In Vivo Use Guide
Electrophysiological and haemodynamic measurements were made in six dogs over successive 30 min periods under control conditions and during infusion of Buquineran at 50, 100 and 250 ug/kg per min (infusion rates 0.91, 1.82 and 4.55 ml/min), respectively.
Route of Administration: Intravenous
In Vitro Use Guide
Buquineran inhibited PDE-II and PDE-III activity with IC50 value of 7.6 uM and 8.6 uM, respectively.
Name Type Language
BUQUINERAN
INN   MART.  
INN  
Official Name English
BUQUINERAN [MART.]
Preferred Name English
1-BUTYL-3-(1-(6,7-DIMETHOXY-4-QUINAZOLINYL)-4-PIPERIDYL)UREA
Systematic Name English
buquineran [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C744
Created by admin on Mon Mar 31 18:33:03 GMT 2025 , Edited by admin on Mon Mar 31 18:33:03 GMT 2025
NCI_THESAURUS C29707
Created by admin on Mon Mar 31 18:33:03 GMT 2025 , Edited by admin on Mon Mar 31 18:33:03 GMT 2025
Code System Code Type Description
MESH
C012675
Created by admin on Mon Mar 31 18:33:03 GMT 2025 , Edited by admin on Mon Mar 31 18:33:03 GMT 2025
PRIMARY
EVMPD
SUB05986MIG
Created by admin on Mon Mar 31 18:33:03 GMT 2025 , Edited by admin on Mon Mar 31 18:33:03 GMT 2025
PRIMARY
EPA CompTox
DTXSID30207924
Created by admin on Mon Mar 31 18:33:03 GMT 2025 , Edited by admin on Mon Mar 31 18:33:03 GMT 2025
PRIMARY
FDA UNII
AWC1VMS3HC
Created by admin on Mon Mar 31 18:33:03 GMT 2025 , Edited by admin on Mon Mar 31 18:33:03 GMT 2025
PRIMARY
NCI_THESAURUS
C74355
Created by admin on Mon Mar 31 18:33:03 GMT 2025 , Edited by admin on Mon Mar 31 18:33:03 GMT 2025
PRIMARY
CAS
59184-78-0
Created by admin on Mon Mar 31 18:33:03 GMT 2025 , Edited by admin on Mon Mar 31 18:33:03 GMT 2025
PRIMARY
SMS_ID
100000088450
Created by admin on Mon Mar 31 18:33:03 GMT 2025 , Edited by admin on Mon Mar 31 18:33:03 GMT 2025
PRIMARY
ChEMBL
CHEMBL26984
Created by admin on Mon Mar 31 18:33:03 GMT 2025 , Edited by admin on Mon Mar 31 18:33:03 GMT 2025
PRIMARY
INN
4477
Created by admin on Mon Mar 31 18:33:03 GMT 2025 , Edited by admin on Mon Mar 31 18:33:03 GMT 2025
PRIMARY
PUBCHEM
71953
Created by admin on Mon Mar 31 18:33:03 GMT 2025 , Edited by admin on Mon Mar 31 18:33:03 GMT 2025
PRIMARY